Alembic
FDA approves Indian firm Alembic’s generic of Teva’s Diamox
February 20, 2019Research and Development ANDA, Alembic, Gujurat, US FDA, diamox, generics
The US FDA has approved Guajarati firm Alembic Pharmaceuticals generic version of Teva’s Acetazolamide sold under the brand name Diamox, …
FDA green-lights Alembic’s cholesterol drug
May 15, 2017Sales and Marketing Alembic, FDA, cholesterol
Alembic Pharmaceuticals has announced that its fenofibric acid delayed-release capsules have been approved by the FDA for reducing high cholesterol …
FDA waves through generic BMS antipsychotic
April 30, 2015Manufacturing and Production, Sales and Marketing Alembic, BMS, FDA, Hetero and Torrent Pharmaceuticals, Teva
The FDA has approved four generic versions of Bristol-Myers Squibb’s top selling Abilify, an atypical antipsychotic drug approved to treat …
Latest content
Five Facts about NHS and primary care
September 5, 2026
AI in pharma: From lab development to patient impact
September 5, 2026
